Abzena poised for big growth
Numis is excited about life sciences group Abzena (ABZA:AIM) ahead of its full year results on 13 June 2017, which is expected to reveal strong top-line growth of 40%.Stefan Hamill from Numis believes that investors can more than...
01 June 2017